MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 3 (2006), Issue 2 (February)

1. Transformation of a prefabricated hydroxyapatite/osteogenic protein-1 implant into a vascularised pedicled bone flap in the human chest.
   Int J Oral Maxillofac Surg, 35(3): 265-9. [Abstract] [Full-text]
2. Daptomycin-rifampin for a recurrent MRSA joint infection unresponsive to vancomycin-based therapy.
   Scand J Infect Dis, 38(2): 133-6. [Abstract] [Full-text]
3. Usefulness of teicoplanin for preventing methicillin-resistant Staphylococcus aureus infections in orthopedic surgery.
   Eur J Clin Microbiol Infect Dis, 25(1): 35-38. [Abstract] [Full-text]
4. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children.
   Pediatrics, 117(2): 433-40. [Abstract] [Full-text]
5. Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals.
   Clin Microbiol Infect, 12(3): 262-9. [Abstract] [Full-text]
6. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
   J Clin Microbiol, 44(2): 655-6. [Abstract] [Full-text]
7. Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus.
   J Clin Microbiol, 44(2): 637-9. [Abstract] [Full-text]
8. Use of cefoxitin-based selective broth for improved detection of methicillin-resistant Staphylococcus aureus.
   J Clin Microbiol, 44(2): 592-4. [Abstract] [Full-text]
9. Performance of MRSA ID, a new chromogenic medium for detection of methicillin-resistant Staphylococcus aureus.
   J Clin Microbiol, 44(2): 586-8. [Abstract] [Full-text]
10. Nasopharyngeal decolonization of methicillin-resistant Staphylococcus aureus can reduce PEG peristomal wound infection.
    Am J Gastroenterol, 101(2): 274-7. [Abstract] [Full-text]
11. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002.
    J Antimicrob Chemother, 57(3): 506-10. [Abstract] [Full-text]
12. Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates.
    J Antimicrob Chemother, 57(3): 461-5. [Abstract] [Full-text]
13. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome.
    J Antimicrob Chemother, 57(3): 511-9. [Abstract] [Full-text]
14. A Randomized Clinical Study of Tea Catechin Inhalation Effects on Methicillin-Resistant Staphylococcus aureus in Disabled Elderly Patients.
    J Am Med Dir Assoc, 7(2): 79-83. [Abstract] [Full-text]
15. Prevalence of and Risk Factors for Carriage of Panton-Valentine Leukocidin-Positive Methicillin-Resistant Staphylococcus aureus Among Residents and Staff of a German Nursing Home.
    Infect Control Hosp Epidemiol, 27(2): 208-11. [Abstract] [Full-text]
16. Methicillin-Resistant Staphylococcus aureus in Canadian Aboriginal People.
    Infect Control Hosp Epidemiol, 27(2): 204-7. [Abstract] [Full-text]
17. Chest Tube-Related Empyema Due to Methicillin-Resistant Staphylococcus aureus: Could the Chest Tube Be Coated With Antiseptics?
    Infect Control Hosp Epidemiol, 27(2): 195-7. [Abstract] [Full-text]
18. The Role of Gowns in Preventing Nosocomial Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA): Gown Use in MRSA Control.
    Infect Control Hosp Epidemiol, 27(2): 191-4. [Abstract] [Full-text]
19. Biofilm Formation by and Accessory Gene Regulator Typing of Methicillin-Resistant Staphylococcus aureus Strains Recovered From Patients With Nosocomial Infections.
    Infect Control Hosp Epidemiol, 27(2): 188-90. [Abstract] [Full-text]
20. Reduction in Incidence of Nosocomial Methicillin-Resistant Staphylococcus aureus (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA.
    Infect Control Hosp Epidemiol, 27(2): 185-7. [Abstract] [Full-text]
21. Evaluation of an Intervention Designed to Decrease the Rate of Nosocomial Methicillin-Resistant Staphylococcus aureus Infection by Encouraging Decreased Fluoroquinolone Use.
    Infect Control Hosp Epidemiol, 27(2): 155-69. [Abstract] [Full-text]
22. Methicillin-Resistant Staphylococcus aureus in German Intensive Care Units During 2000-2003: Data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units).
    Infect Control Hosp Epidemiol, 27(2): 146-54. [Abstract] [Full-text]
23. Management of Outbreaks of Methicillin-Resistant Staphylococcus aureus Infection in the Neonatal Intensive Care Unit: A Consensus Statement.
    Infect Control Hosp Epidemiol, 27(2): 139-45. [Abstract] [Full-text]
24. Clinical and Laboratory Features of Community-Associated Methicillin-Resistant Staphylococcus aureus: Is It Really New?
    Infect Control Hosp Epidemiol, 27(2): 133-8. [Abstract] [Full-text]
25. A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients' acquisition of MRSA.
    Infect Control Hosp Epidemiol, 27(2): 127-32. [Abstract] [Full-text]
26. What Proportion of Hospital Patients Colonized With Methicillin-Resistant Staphylococcus aureus Are Identified by Clinical Microbiological Cultures?
    Infect Control Hosp Epidemiol, 27(2): 116-21. [Abstract] [Full-text]
27. Air ionisation and colonisation/infection with methicillin-resistant Staphylococcus aureus and Acinetobacter species in an intensive care unit.
    Intensive Care Med, 32(2): 315-7. [Abstract] [Full-text]
28. Methicillin-resistant Staphylococcus aureus infections in acute rhinosinusitis.
    Laryngoscope, 116(2): 288-91. [Abstract] [Full-text]
29. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study.
    Crit Care, 10(1): R25. [Abstract] [Full-text]
30. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
    J Hosp Infect, 62(3): 327-32. [Abstract] [Full-text]
31. Methicillin-resistant Staphylococcus aureus: awareness and perceptions.
    J Hosp Infect, 62(3): 333-7. [Abstract] [Full-text]
32. Synthesis and potent antimicrobial activities of some novel retinoidal monocationic benzimidazoles.
    Arch Pharm (Weinheim), 339(2): 74-80. [Abstract] [Full-text]
33. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study.
    Clin Infect Dis, 42(6): 778-84. [Abstract] [Full-text]
34. Evaluation of six agglutination tests for Staphylococcus aureus identification depending upon local prevalence of meticillin-resistant S. aureus (MRSA).
    J Med Microbiol, 55: 283-90. [Abstract] [Full-text]
35. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains.
    Lett Appl Microbiol, 42(3): 215-21. [Abstract] [Full-text]
36. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.
    Int J Antimicrob Agents, 27(3): 201-11. [Abstract] [Full-text]
37. Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.
    Int J Antimicrob Agents, 27(3): 229-35. [Abstract] [Full-text]
38. Evaluating the probability of previously unknown carriage of MRSA at hospital admission.
    Am J Med, 119(3): 275.e15-23. [Abstract] [Full-text]
39. Methicillin-resistant Staphylococcus aureus in the community in West Essex.
    Epidemiol Infect, 134(2): 301-5. [Abstract] [Full-text]
40. Abietanes from Plectranthus grandidentatus and P. hereroensis against methicillin- and vancomycin-resistant bacteria.
    Phytomedicine, 13(4): 267-71. [Abstract] [Full-text]
41. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements.
    Antimicrob Agents Chemother, 50(3): 1001-12. [Abstract] [Full-text]
42. Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study.
    Antimicrob Agents Chemother, 50(3): 862-7. [Abstract] [Full-text]
43. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus.
    J Infect, 52(3): 157-68. [Abstract] [Full-text]
44. Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards.
    J Infect Chemother, 12(1): 47-50. [Abstract] [Full-text]
45. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Crit Care Med, 34(3): 700-6. [Abstract] [Full-text]
46. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000-2003, increasing incidence and regional differences.
    BMC Infect Dis, 6(1): 30. [Abstract] [Full-text]
47. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
    Pharmacotherapy, 26(3): 347-52. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.